The relevant information included in this section is exactly as published on the website of the National Securities Market Commission (CNMV)

Filter results
Date Title Content PDF
27/11/2020 On business and financial situation The Company publishes the results of the PRISMA-3 study of the efficacy and safety of Doria® in schizophrenic patients in the journal npj Schizophrenia
24/11/2020 On business and financial situation The Company releases the presentation related to its strategy update because of the 2020 Capital Markets Day.
13/11/2020 Other relevant information The Company informs about the dividends payment 
5/11/2020 On business and financial situation The company releases the press release related to the 2020 first nine months financial results
5/11/2020 On business and financial situation ROVI releases the 2020 First Nine Months Results presentation
20/10/2020 Announcement of general shareholders’ meeting ROVI releases the information related to its General Shareholders Meeting
15/10/2020 Announcement of general shareholders’ meeting   In view of the exceptional circumstances derived from the spread of Covid-19, the Company has agreed that the Ordinary General Meeting be held by exclusively telematic means.  
1/10/2020 Liquidity contracts and specialists Liquidity contract: transactions conducted in the third quarter of 2020
11/09/2020 Announcement of general shareholders’ meeting Rovi releases the information related to its 2020 General Shareholders Meeting.
27/07/2020 On business and financial situation The company releases the press release related to the 2020 first half financial results

Pages